Hostname: page-component-7c8c6479df-5xszh Total loading time: 0 Render date: 2024-03-28T22:59:09.026Z Has data issue: false hasContentIssue false

Initiation, changes in use and effectiveness of highly active anti-retroviral therapy in a cohort of injecting drug users

Published online by Cambridge University Press:  09 October 2002

J. M. EGEA
Affiliation:
Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain
R. MUGA
Affiliation:
Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain
G. SIRERA
Affiliation:
HIV/Aids Unit, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain
B. CLOTET
Affiliation:
HIV/Aids Unit, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain
J. TOR
Affiliation:
Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain
M. ARDÈVOL
Affiliation:
Hospital Pharmacy, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain
C. REY-JOLY
Affiliation:
Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain
A. MUÑOZ
Affiliation:
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The prevalence of anti-retroviral therapy (ART) use over time and the incidence of AIDS in a cohort of HIV-seroconverting injecting drug users (IDUs) were assessed by means of a hospital-based study of IDUs with a well documented date of HIV infection. Use of ART and clinical endpoints were assessed by hospital records. Three calendar periods (before 1992, 1992–6 and 1997–2000) were defined as corresponding to modalities of ART available. Prevalence of ART usage in each calendar period, changes in medication and, hazard of AIDS in patients reaching the same duration of HIV infection at different calendar periods were analysed. In total, 132 IDUs with a median age of 23 years at seroconversion were followed up for 6.8 years (median) (range 0.2–15.7). At the end of the study, 58 patients (44%) had developed AIDS. Before the introduction of highly active anti-retroviral therapy (HAART) 12% of patients were on ART. Starting in 1997, an increasing proportion were receiving HAART with a prevalence of 39.5% by January 2000. Taking 1992–6 as the reference category the relative hazard of AIDS during 1997–2000 was 0.42 (95% CI, 0.1–1.1) (P = 0.09). A 40% penetration of HAART in a cohort of IDUs with known dates of seroconversion resulted in a 58% reduction of the hazard of AIDS.

Type
Research Article
Copyright
© 2002 Cambridge University Press